SGMO icon

Sangamo Therapeutics
SGMO

Overview Fund Activity

182 hedge funds and large institutions have $315M invested in Sangamo Therapeutics in 2022 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 63 increasing their positions, 60 reducing their positions, and 30 closing their positions.

Holders
182
Holders Change
-14
Holders Change %
-7.14%
% of All Funds
2.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
63
Reduced
60
Closed
30
Calls
$1.18M
Puts
$639K
Net Calls
+$542K
Net Calls Change
+$64K

Top Buyers

1
State Street
1
State Street
Massachusetts
$30.7M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$44.1M
3
BlackRock
3
BlackRock
New York
$48.2M
4
Citadel Advisors
4
Citadel Advisors
Florida
$4.41M
5
LFCM
5
Long Focus Capital Management
Puerto Rico
$3.37M

Top Sellers

1
Manulife (Manufacturers Life Insurance)
1
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$164K
2
State of New Jersey Common Pension Fund D
2
State of New Jersey Common Pension Fund D
New Jersey
$0
3
WA
3
Wasatch Advisors
Utah
$39.7M
4
Millennium Management
4
Millennium Management
New York
$666K
5
CSS
5
Cubist Systematic Strategies
Connecticut
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
LPL Financial
201
LPL Financial
California
– -$52K -10,671 Closed
AIM
202
Axiom Investment Management
New York
– -$38K -8,000 Closed
QT
203
Quantbot Technologies
New York
– -$18K -3,800 Closed
BWP
204
Baldwin Wealth Partners
Massachusetts
– -$12K -2,500 Closed
HI
205
Hudock Inc
Pennsylvania
– -$10K -2,200 Closed
IAMOG
206
Investors Asset Management of Georgia
Georgia
– -$9K -1,800 Closed
WIM
207
Westside Investment Management
California
– -$2 -600 Closed
CWM
208
Castle Wealth Management
Florida
– -$2K -400 Closed
5 6 7 8
9